These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28646624)

  • 1. Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.
    D'Arena G; Vitale C; Perbellini O; Coscia M; La Rocca F; Ruggieri V; Visco C; Di Minno NMD; Innocenti I; Pizza V; Deaglio S; Di Minno G; Giudice A; Calapai G; Musto P; Laurenti L; Iorio EL
    Eur J Haematol; 2017 Oct; 99(4):306-314. PubMed ID: 28646624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mode of delivery on pro-oxidant/antioxidant balance in fetal circulation.
    Kobayashi H; Iorio EL; Yoshino A
    J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3294-3299. PubMed ID: 30231659
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of prolonged submaximal exercise on serum oxidative stress biomarkers (d-ROMs, MDA, BAP) and oxidative stress index in endurance horses.
    Brkljača Bottegaro N; Gotić J; Šuran J; Brozić D; Klobučar K; Bojanić K; Vrbanac Z
    BMC Vet Res; 2018 Jul; 14(1):216. PubMed ID: 29980209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in chronic lymphocytic leukemia: still a matter of debate.
    D'Arena G; Seneca E; Migliaccio I; De Feo V; Giudice A; La Rocca F; Capunzo M; Calapai G; Festa A; Caraglia M; Musto P; Iorio EL; Ruggieri V
    Leuk Lymphoma; 2019 Apr; 60(4):867-875. PubMed ID: 30234409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia.
    Sulda ML; Kuss BJ; Hall RK; Bailey S; Macardle PJ
    Intern Med J; 2012 Feb; 42(2):137-46. PubMed ID: 20561095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
    International CLL-IPI working group
    Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
    Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Rozman M; Aymerich M; López C; Costa D; Carrió A; Villamor N; Montserrat E
    Br J Haematol; 2016 Jan; 172(1):48-55. PubMed ID: 26559905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
    Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
    Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
    Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
    Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
    Ibrahem L; Elderiny WE; Elhelw L; Ismail M
    Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
    Nückel H; Switala M; Collins CH; Sellmann L; Grosse-Wilde H; Dührsen U; Rebmann V
    Clin Immunol; 2009 Jun; 131(3):472-80. PubMed ID: 19318232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
    Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia.
    Wang WT; Zhu HY; Wu YJ; Xia Y; Wu JZ; Wu W; Liang JH; Wang L; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):449-457. PubMed ID: 29299750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
    Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
    Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential biomarker for fatigue: Oxidative stress and anti-oxidative activity.
    Fukuda S; Nojima J; Motoki Y; Yamaguti K; Nakatomi Y; Okawa N; Fujiwara K; Watanabe Y; Kuratsune H
    Biol Psychol; 2016 Jul; 118():88-93. PubMed ID: 27224647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.
    De Luca L; D'Arena G; Simeon V; Trino S; Laurenzana I; Caivano A; La Rocca F; Villani O; Mansueto G; Deaglio S; Innocenti I; Laurenti L; Molica S; Pietrantuono G; De Stradis A; Del Vecchio L; Musto P
    Leuk Lymphoma; 2017 Jun; 58(6):1424-1432. PubMed ID: 27739922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
    Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
    van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
    Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.